References
DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1998; 37: 667–87
DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic andmolecular implications for identifying diabetes genes. Diabetes Rev 1997; 5: 177–269
Gulli G, Ferrannini E, Stern M, at al. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992; 41: 1575–86
DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989; 38: 387–95
Consoli A, Nurjhan N, Capani F, et al. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989; 38: 550–7
DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318–68
DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995; 333: 541–9
Garber AJ, Duncan TG, Goodman AM, et al. Efficacy of metformin in type 2 diabetes: results of a double-blind, placebo-controlled, dose response trial. Am J Med 1997; 103(6): 491–7
Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4059–67
Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 550–4
Rosetti L, DeFronzo RA, Gherzi R, et al. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. Metabolism 1990; 39: 425–35
Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care 1990; 13: 696–704
Inzucchi SE, Maggs DG, Spollett GR, et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 1998; 338: 867–72
Giugliano D, Quatrano A, Consoli G, et al. Metformin for obese, insulin resistant diabetic patients: improvement in glycemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol 1993; 44: 107–12
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeFronzo, R.A. Pathogenesis of Type 2 Diabetes. Drugs 58 (Suppl 1), 29–30 (1999). https://doi.org/10.2165/00003495-199958001-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199958001-00008